跳至主要内容
临床试验/NCT00665574
NCT00665574终止不适用

A Prospective, Multi-center, Randomized, Double-blind Feasibility Study to Evaluate the Safety and Performance of ActaVisc and ActaVisc Mx Intra-articular Injection for Management of Pain Associated With Osteoarthritis in the Knee.

Carbylan Therapeutics, Inc.2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
23
试验地点
2
主要终点
Change from Baseline in the WOMAC Pain subscale average score for the treatment knee.

研究概览

简要总结

To evaluate the safety and performance of ActaVisc™ intra-articular injection (ActaVisc) and ActaVisc Mx, for management of pain associated with osteoarthritis in the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Osteoarthritis (OA) grade 2 or
  • •Symptoms in the treatment knee for at least 12 months.
  • •Fully ambulatory patient.

排除标准

  • •Secondary OA resulting from rheumatoid arthritis, chondrocalcinosis, osteonecrosis, chronic fibromyalgia or other autoimmune disease.
  • •Generalized symptomatic OA in lower extremity joints other than the knees, inflammatory joint disease, bursitis, OA in the hips, or other condition that may interfere with study assessments.

研究组 & 干预措施

1

Experimental

ActaVisc

干预措施: ActaVisc and ActaVisc Mx Intra-articular Injection (Other)

2

Experimental

ActaVisc Mx Intra-articular Injection

干预措施: ActaVisc and ActaVisc Mx Intra-articular Injection (Other)

3

Placebo Comparator

Saline

干预措施: ActaVisc and ActaVisc Mx Intra-articular Injection (Other)

4

Active Comparator

Corticosteroid

干预措施: ActaVisc and ActaVisc Mx Intra-articular Injection (Other)

结局指标

主要结局

Change from Baseline in the WOMAC Pain subscale average score for the treatment knee.

时间窗: 26 weeks post treatment

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验